Barbara MacGregor‐Cortelli
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Owen A. O’Connor (10 shared papers)Craig H. Moskowitz (8 shared papers)Andrew D. Zelenetz (8 shared papers)Carol S. Portlock (4 shared papers)Paul A. Hamlin (5 shared papers)David P. Schenkein (7 shared papers)David J. Straus (5 shared papers)Steven M. Horwitz (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (3 papers)British Journal of Haematology (2 papers)Clinical Oncology (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- United States
In The Last Decade
Barbara MacGregor‐Cortelli
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 59
- Pathology and Forensic Medicine 446
- Genetics 193
- Hematology 193
- Dermatology 118
- Oncology 344
Countries citing papers authored by Barbara MacGregor‐Cortelli
This map shows the geographic impact of Barbara MacGregor‐Cortelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara MacGregor‐Cortelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara MacGregor‐Cortelli more than expected).
Fields of papers citing papers by Barbara MacGregor‐Cortelli
This network shows the impact of papers produced by Barbara MacGregor‐Cortelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara MacGregor‐Cortelli. The network helps show where Barbara MacGregor‐Cortelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara MacGregor‐Cortelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 461 | |
| 2 | 2005 | 345 | |
| 3 | 2009 | 131 | |
| 4 | 2007 | 68 | |
| 5 | 2006 | 36 | |
| 6 | 2009 | 18 | |
| 7 | 2006 | 17 | |
| 8 | 2004 | 16 | |
| 9 | 2003 | 10 | |
| 10 | 2007 | 9 | |
| 11 | Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II. | 2004 | 5 |
| 12 | 2005 | 3 |
About Barbara MacGregor‐Cortelli
Barbara MacGregor‐Cortelli is a scholar working on Pathology and Forensic Medicine, Genetics, Molecular Biology, Dermatology and Hematology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cutaneous lymphoproliferative disorders research (2 papers), T-cell and Retrovirus Studies (2 papers), Ubiquitin and proteasome pathways (2 papers), Multiple Myeloma Research and Treatments (2 papers), Viral-associated cancers and disorders (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (446 citations), Genetics (193 citations), Hematology (193 citations), Dermatology (118 citations) and Oncology (344 citations). Barbara MacGregor‐Cortelli has collaborated with scholars based in United States. Frequent co-authors include Owen A. O’Connor, Craig H. Moskowitz, Andrew D. Zelenetz, Carol S. Portlock, Paul A. Hamlin, David P. Schenkein, David J. Straus, Steven M. Horwitz, Dixie Esseltine and Michael D. Stubblefield. Their work appears in journals such as Journal of Clinical Oncology, Blood, British Journal of Haematology, Clinical Oncology and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.